Detalhe da pesquisa
1.
Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.
Antimicrob Agents Chemother
; 66(6): e0022222, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35532238
2.
Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.
N Engl J Med
; 388(9): 854-857, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734885
3.
Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
J Virol
; 92(7)2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321318
4.
Correlation of Severity of Human Tick-Borne Encephalitis Virus Disease and Pathogenicity in Mice.
Emerg Infect Dis
; 24(9): 1709-1712, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124404
5.
Cell-type- and region-specific restriction of neurotropic flavivirus infection by viperin.
J Neuroinflammation
; 15(1): 80, 2018 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29544502
6.
Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1.
J Neuroinflammation
; 13: 22, 2016 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819220
7.
Erratum for Panayiotou et al., "Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation".
J Virol
; 92(12)2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29844247
8.
Reverse genetic systems of SARS-CoV-2 for antiviral research.
Antiviral Res
; 210: 105486, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657881
9.
CAPRIN1 Is Required for Control of Viral Replication Complexes by Interferon Gamma.
mBio
; 14(3): e0017223, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052473
10.
Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants.
mBio
; 14(1): e0317622, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625591
11.
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster.
Nat Med
; 29(2): 344-347, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473500
12.
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1.
Emerg Microbes Infect
; 12(2): 2271089, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824708
13.
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness.
bioRxiv
; 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034621
14.
An Integrated Research-Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay.
Viruses
; 15(9)2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766263
15.
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages.
Emerg Microbes Infect
; 12(1): e2161422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594261
16.
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine.
Cell Rep
; 41(9): 111729, 2022 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402138
17.
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2.
Nat Commun
; 13(1): 2956, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618703
18.
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of mRNA vaccine.
bioRxiv
; 2022 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35923309
19.
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection.
Nat Commun
; 13(1): 852, 2022 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140233
20.
Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants.
bioRxiv
; 2022 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36299433